NCT04280705: A reported trial by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT04280705 |
|---|---|
| Title | A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Feb. 21, 2020 |
| Completion date | May 21, 2020 |
| Required reporting date | May 21, 2021, midnight |
| Actual reporting date | Sept. 16, 2020 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |